How Will Deep Brain Stimulation Affect Neurological and Psychiatric Drug Markets?

Table of Contents

• Executive Summary
• Strategic Implications
• Stakeholder Implications
• Introduction
• Overview of DBS
• DBS for Specific Therapeutic Areas
• Parkinson's Disease
• Epilepsy
• Psychiatric Disorders: OCD and Depression
• Headaches
• Companies Developing DBS Systems
• Medtronic
• NeuroPace
• Cyberonics
• Boston Scientific
• Medtrode
• Advanced Neuromodulation Systems
• Impact of DBS on Drug Markets
• Market Implications
• DBS and the PD Market
• DBS and the Epilepsy Market
• DBS and the Psychiatric Markets
• DBS and the Headache Market
• Codevelopment of Pharmacological Agents and DBS
• Outlook for DBS in the Marketplace
• Bibliography

Tables

• 1. Brain Regions Implicated in Epileptic Seizures
• 2. Companies Developing DBS Devices

Figures

• 1. Regions of the Brain Targeted for Deep Brain Stimulation
• 2. Schematic of Deep Brain Stimulation
• 3. Growth of DBS Procedures, by Indication, 2005-2015